Keizo Anzai Selected Research

Keizo Anzai Research Topics

Disease

15	Non-alcoholic Fatty Liver Disease 01/2022 - 09/2013
13	Insulin Resistance 11/2021 - 10/2007
11	Liver Cirrhosis (Hepatic Cirrhosis) 10/2020 - 05/2013
8	Fibrosis (Cirrhosis) 01/2022 - 01/2013
7	Inflammation (Inflammations) 02/2024 - 04/2011
6	Hepatocellular Carcinoma (Hepatoma) 08/2020 - 01/2013
6	Neoplasms (Cancer) 08/2020 - 01/2010
5	Obesity 01/2022 - 09/2008
5	Infections 02/2021 - 10/2017
5	Glucose Intolerance 01/2021 - 12/2007
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2021 - 04/2005
4	Fatty Liver 01/2021 - 11/2014
3	Type 2 Diabetes Mellitus (MODY) 11/2021 - 12/2007
3	Body Weight (Weight, Body) 01/2020 - 01/2015
3	Diabetes Mellitus 02/2016 - 01/2011
3	Chronic Hepatitis C 01/2015 - 04/2011
3	Liver Diseases (Liver Disease) 11/2014 - 01/2010
2	Autoimmune Diseases (Autoimmune Disease) 02/2024 - 04/2005
2	Hyperglycemia 01/2022 - 04/2007
2	Hiatal Hernia 01/2021 - 07/2019
2	Gastroesophageal Reflux (GERD) 01/2021 - 07/2019
2	Hepatitis 04/2020 - 01/2016
2	Sarcopenia 03/2018 - 02/2016
2	Alcoholic Fatty Liver 03/2015 - 09/2013
2	Dyslipidemias (Dyslipidemia) 11/2014 - 07/2014
2	Anemia 01/2013 - 01/2011
2	Hepatitis C 04/2012 - 04/2011
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2023
1	Hypoglycemia (Reactive Hypoglycemia) 01/2023
1	Chronic Obstructive Pulmonary Disease (COPD) 08/2022
1	Constipation 08/2021
1	Nausea 08/2021
1	Vomiting 08/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021
1	Peptic Esophagitis (Reflux Esophagitis) 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	COVID-19 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Abdominal Pain (Pain, Abdominal) 01/2020
1	Myocardial Ischemia (Ischemic Heart Diseases) 07/2019
1	Hypoxia (Hypoxemia) 02/2019

Drug/Important Bio-Agent (IBA)

16	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 10/2007
7	Insulin (Novolin)FDA Link 01/2023 - 04/2005
5	AlbuminsIBA 08/2022 - 01/2013
5	Alanine Transaminase (SGPT)IBA 11/2014 - 04/2011
4	Hemoglobins (Hemoglobin)IBA 02/2021 - 01/2013
4	Blood Glucose (Blood Sugar)IBA 01/2021 - 11/2014
4	Serum AlbuminIBA 01/2021 - 08/2014
3	TYK2 Kinase (Tyrosine Kinase 2)IBA 02/2024 - 09/2017
3	imidazoleacetic acid (IMAC)IBA 01/2021 - 09/2013
3	InterferonsIBA 08/2018 - 04/2012
3	Triglycerides (Triacylglycerol)IBA 11/2015 - 11/2014
3	HDL CholesterolIBA 11/2014 - 04/2011
2	ipragliflozinIBA 01/2022 - 01/2022
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 08/2020
2	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 04/2020
2	AcidsIBA 01/2021 - 07/2019
2	Liraglutide FDA Link 08/2020 - 03/2015
2	Glucagon-Like Peptide-1 ReceptorIBA 08/2020 - 03/2015
2	Biomarkers (Surrogate Marker)IBA 06/2020 - 01/2018
2	Antiviral Agents (Antivirals)IBA 04/2020 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2014
2	Branched-Chain Amino AcidsIBA 03/2018 - 03/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2017 - 04/2012
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 09/2017 - 01/2017
2	Fetal Proteins (Fetoprotein)IBA 02/2016 - 01/2013
2	CholesterolIBA 11/2015 - 11/2014
2	Ribavirin (Virazole)FDA LinkGeneric 01/2015 - 04/2012
2	LDL CholesterolIBA 11/2014 - 07/2014
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2013 - 07/2011
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2013 - 07/2011
2	LipidsIBA 01/2010 - 07/2009
1	deucravacitinibIBA 02/2024
1	C-Reactive ProteinIBA 08/2022
1	SodiumIBA 01/2022
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 01/2022
1	Pioglitazone (Actos)FDA Link 01/2022
1	Interferon Receptors (Interferon Receptor)IBA 11/2021
1	C-PeptideIBA 11/2021
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 08/2021
1	AntiemeticsIBA 08/2021
1	Palonosetron (Aloxi)FDA Link 08/2021
1	Aprepitant (Emend)FDA Link 08/2021
1	AntacidsIBA 01/2021
1	Proton Pump InhibitorsIBA 01/2021
1	PotassiumIBA 01/2021
1	Complement System Proteins (Complement)IBA 06/2020
1	RNA (Ribonucleic Acid)IBA 04/2020
1	Surface Antigens (Surface Antigen)IBA 04/2020
1	Epidermal Growth Factor (EGF)IBA 01/2020
1	antiarrhythmic peptide (AAP)IBA 01/2020
1	MitogensIBA 01/2020
1	Sodium-Glucose Transport ProteinsIBA 01/2020
1	Hypoxia-Inducible Factor 1IBA 02/2019

Therapy/Procedure

6	Therapeutics 02/2021 - 04/2005
2	Injections 11/2021 - 01/2013
2	Drug Therapy (Chemotherapy) 08/2021 - 03/2015
1	Glycemic Control 01/2022
1	Intravenous Administration 08/2021
1	Personal Protective Equipment 01/2020